This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Janssen Pharmaceutica Nv, Protagonist Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,101 
1 out of 35 
Years Active: 2024
Title: Nathalie Mertens: Innovator in Autoimmune Treatment
Introduction
Nathalie Mertens is a prominent inventor based in Beerse, Belgium. She has made significant contributions to the field of autoimmune inflammation through her innovative research and development of peptide inhibitors.
Latest Patents
Mertens holds a patent for "Compositions of peptide inhibitors of Interleukin-23 receptor." This invention relates to compositions of peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salt or solvate forms thereof. The corresponding pharmaceutical compositions, methods, and uses are aimed at treating autoimmune inflammation and related diseases and disorders. She has 1 patent to her name.
Career Highlights
Throughout her career, Nathalie has worked with notable companies such as Janssen Pharmaceutica NV and Protagonist Therapeutics, Inc. Her work has been instrumental in advancing therapeutic options for patients suffering from autoimmune conditions.
Collaborations
Mertens has collaborated with esteemed colleagues, including Giustino Di Pretoro and Dajun Sun, contributing to her innovative research and development efforts.
Conclusion
Nathalie Mertens is a key figure in the field of autoimmune treatment, with her patented inventions paving the way for new therapeutic approaches. Her dedication to research and collaboration continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile